Hilton Worldwide Holdings (NYSE:HLT) released its fourth quarter and full-year 2024 financial results today, demonstrating robust performance and surpassing expectations in key areas. The company ...

Blackstone Minerals (ASX:BSX) announced a merger with IDM International to jointly explore the world-class Mankayan Copper-Gold Porphyry Project in the Philippines. The merger aims to leverage ...

The U.S. Department of Justice (DOJ) has charged Canadian hacker Andean Medjedovic, 22, with stealing approximately $65 million from two decentralised finance (DeFi) platforms, KyberSwap and Indexed ...

BP has put the brakes on its $1 billion-plus energy hub development at the Kwinana industrial site, signalling a major shift in its green energy strategy. The decision, which could lead to the loss of ...

Trigg Minerals (ASX:TMG) has announced the expansion of its antimony portfolio by acquiring the historic Bukkulla Mine and extending its reach into the Nundle Goldfield in New South Wales. The ...

Native Mineral Resources (ASX:NMR) has completed a $4 million shortfall placement as part of its $15.9 million non-renounceable entitlement offer. The funding milestone triggers a substantial ...

Battery Age Minerals (ASX: BM8) will acquire a majority interest in the El Aguila Gold and Silver Project in Santa Cruz, Argentina. Through a farm-in agreement with Fredonia Mining, the company will ...

Comcast Corporation (NASDAQ:CMCSA) today announced its strongest financial performance in company history for the fourth quarter of 2024. The company reported record revenue, EBITDA, and earnings per ...

Flagstar Financial (NYSE:FLG) today announced its fourth quarter and full-year 2024 financial results, reporting a significant narrowing of losses in the fourth quarter compared to previous periods, ...

Canterbury Resources (ASX:CBY) reported advancements in its 2024 drilling program at the Briggs Copper Project, Queensland. The final assay results confirm a new Southern porphyry discovery, extending ...

Matsa Resources (ASX:MAT) announced a capital raising of $3.1 million, facilitated through a share placement to three corporate investors at 3.8 cents per share. The funds will expedite the ...

Alterity Therapeutics (ASX:ATH), a biotechnology company focused on neurodegenerative diseases, announced positive results from its Phase 2 clinical trial of ATH434 for early-stage multiple system ...